Last updated: 23 July 2019 at 6:00am EST

John H Friedman Net Worth




The estimated Net Worth of John H Friedman is at least 11.1 百万$ dollars as of 7 November 2013. John Friedman owns over 90,130 units of Cardiovascular Systems stock worth over 3,322,240$ and over the last 19 years John sold CSII stock worth over 7,776,275$.

John Friedman CSII stock SEC Form 4 insiders trading

John has made over 13 trades of the Cardiovascular Systems stock since 2011, according to the Form 4 filled with the SEC. Most recently John sold 90,130 units of CSII stock worth 2,677,762$ on 7 November 2013.

The largest trade John's ever made was selling 90,130 units of Cardiovascular Systems stock on 7 November 2013 worth over 2,677,762$. On average, John trades about 24,323 units every 31 days since 2006. As of 7 November 2013 John still owns at least 166,112 units of Cardiovascular Systems stock.

You can see the complete history of John Friedman stock trades at the bottom of the page.



What's John Friedman's mailing address?

John's mailing address filed with the SEC is C/O ACORDA THERAPEUTICS, INC, 15 SKYLINE DRIVE, HAWTHORNE, NY, 10532.

Insiders trading at Cardiovascular Systems

Over the last 16 years, insiders at Cardiovascular Systems have traded over 72,999,461$ worth of Cardiovascular Systems stock and bought 949,532 units worth 8,687,068$ . The most active insiders traders include Capital Management Lp CamberAugustine LawlorCapital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of 338,920$. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth 48,220$.



What does Cardiovascular Systems do?

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.



Complete history of John Friedman stock trades at Acorda Therapeutics Inc、Cardiovascular Systems

インサイダー
取引
取引
合計金額
John H Friedman
ディレクター
販売 2,677,762$
7 Nov 2013
John H Friedman
ディレクター
販売 1,000,699$
10 Sep 2013
John H Friedman
ディレクター
販売 572,029$
14 Feb 2012
John H Friedman
ディレクター
販売 497,797$
30 Jan 2012
John H Friedman
ディレクター
販売 597,379$
25 Jan 2012
John H Friedman
ディレクター
販売 433,111$
20 Jan 2012
John H Friedman
ディレクター
販売 264,205$
18 Jan 2012
John H Friedman
ディレクター
販売 122,213$
13 Jan 2012
John H Friedman
ディレクター
販売 182,859$
11 Jan 2012
John H Friedman
ディレクター
販売 281,340$
9 Jan 2012
John H Friedman
ディレクター
販売 364,267$
5 Jan 2012
John H Friedman
ディレクター
販売 532,364$
3 Jan 2012
John H Friedman
ディレクター
販売 250,250$
28 Nov 2011


Cardiovascular Systems executives and stock owners

Cardiovascular Systems executives and other stock owners filed with the SEC include: